NTLA INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Intellia Therapeutics, Inc. Shareholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
Portfolio Pulse from
A class action lawsuit has been filed against Intellia Therapeutics, Inc. (NASDAQ:NTLA) by Bronstein, Gewirtz & Grossman, LLC. The lawsuit alleges violations of federal securities laws for investors who acquired Intellia securities between July 30, 2024, and January 8, 2025.
March 17, 2025 | 11:15 am
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Intellia Therapeutics is facing a class action lawsuit for alleged securities law violations, which could impact its stock price negatively in the short term.
The announcement of a class action lawsuit typically leads to negative sentiment among investors, potentially causing a decline in stock price. The lawsuit alleges violations of securities laws, which is a serious concern for shareholders.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100